CDRH’s Use Of Advisory Panelists In Postmarket Realm Sets New Precedent
This article was originally published in The Gray Sheet
CDRH plans to add several electrophysiologists to its Circulatory System Devices Advisory Panel to help assess the safety of ICDs and pacemakers already on the market
You may also be interested in...
Guidant has relied too much on engineers and not enough on physicians in evaluating the postmarket performance of its implantable cardiac rhythm management products, making it possible for device problems to go unaddressed, according to an expert panel commissioned by the company
The Heart Rhythm Society should work with FDA and manufacturers to educate physicians on realistic expectations for ICD and pacemaker performance, according to participants at the Policy Conference on Pacemaker and ICD Performance
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.